Technical Analysis for ELEV - Elevation Oncology, Inc.

Grade Last Price % Change Price Change
D 8.2 0.00% 0.00
ELEV closed unchanged on Monday, August 2, 2021, on 61 percent of normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A N/A Down
Historical ELEV trend table...

Date Alert Name Type % Chg
New Downtrend Bearish 0.00%
Shooting Star Candlestick Bearish 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Buy Signal Bullish 0.00%
Hot IPO Pullback Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Older End-of-Day Signals for ELEV ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 2 % about 11 hours ago
60 Minute Opening Range Breakdown about 13 hours ago
Down 1% about 13 hours ago
Hot IPO Pullback Entry about 14 hours ago
Rose Above Previous Day's High about 14 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically-defined patient populations in the United States. Its lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. The company was incorporated in 2019 and is based in New York, New York.

Sector: Other
Industry: Other
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Clinical Medicine Pharmaceutical Industry Immunology Health Sciences Pharmacy Treatment Of Cancer Monoclonal Antibody Advanced Solid Tumors

Is ELEV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 16.22
52 Week Low 7.73
Average Volume 102,804
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 11.81
10-Day Moving Average 9.01
Average True Range 1.48
ADX 25.85
+DI 13.53
-DI 22.60
Chandelier Exit (Long, 3 ATRs) 11.78
Chandelier Exit (Short, 3 ATRs) 12.17
Upper Bollinger Bands 17.87
Lower Bollinger Band 5.74
Percent B (%b) 0.2
BandWidth 102.68
MACD Line -2.35
MACD Signal Line -1.75
MACD Histogram -0.6068
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.02
Resistance 3 (R3) 10.16 9.69 9.71
Resistance 2 (R2) 9.69 9.23 9.62 9.61
Resistance 1 (R1) 8.95 8.95 8.72 8.81 9.51
Pivot Point 8.48 8.48 8.37 8.41 8.48
Support 1 (S1) 7.74 8.02 7.51 7.60 6.89
Support 2 (S2) 7.27 7.74 7.20 6.79
Support 3 (S3) 6.53 7.27 6.69
Support 4 (S4) 6.39